SableBio provides an AI‑powered platform that predicts drug safety outcomes, delivering augmented‑in Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2025-09-10 | £4.4M |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| ALEXANDER DE GIORGIO | ORDINARY | 1,000,000 | 50.0% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
1 more shareholder on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity SABLEBIO LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. SABLEBIO LIMITED has 2 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
(A) THE ORDINARY SHARES HAVE ATTACHED TO THEM FULL RIGHTS IN RESPECT OF VOTING. (B) THE RIGHT TO PARTICIPATE IN A DIVIDEND IN PROPORTION TO THE NUMBER OF SHARES HELD (C) THE RIGHT TO PARTICIPATE IN A DISTRIBUTION OF CAPITAL IN PROPORTION TO THE NUMBER OF SHARES HELD, SUBJECT TO THE RIGHTS ATTACHING TO THE SEED PREFERRED SHARES (D) THE SHARES ARE NON-REDEEMABLE.
(A) THE SEED PREFERRED SHARES HAVE ATTACHED TO THEM FULL RIGHTS IN RESPECT OF VOTING. (B) THE RIGHT TO PARTICIPATE IN A DIVIDEND IN PROPORTION TO THE NUMBER OF SHARES HELD (C) IN A DISTRIBUTION OF CAPITAL, THE RIGHT TO RECEIVE THE GREATER OF: AN AMOUNT EQUAL TO THE SUBSCRIPTION PRICE (PROVIDED THAT IF THERE ARE INSUFFICIENT SURPLUS ASSETS TO PAY SUCH AMOUNTS, 99.99999% OF THE REMAINING SURPLUS ASSETS SHALL BE DISTRIBUTED TO THE HOLDERS OF THE SEED PREFERRED SHARES IN PROPORTION TO THE SUBSCRIPTION PRICE PAID ON THOSE SHARES), OR AN AMOUNT PER SHARE EQUIVALENT TO THAT WHICH THE HOLDERS OF SEED PREFERRED SHARES WOULD HAVE RECEIVED HAD SUCH SHARES CONVERTED INTO ORDINARY SHARES IMMEDIATLEY PRIOR TO THE RETURN OF CAPITAL (D) THE SHARES ARE NON-REDEEMABLE.
These are the directors and secretaries who have left SABLEBIO LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.